IQ trajectory, cognitive reserve, and clinical outcome following a first episode of psychosis: A 3-year longitudinal study

Schizophrenia Bulletin

Volumn 37, Issue 4, 2011, Pages 768-777

  Leeson, Verity C ^a,b   Sharma, Pranev ^b   Harrison, Masuma ^b   Ron, Maria A ^a   Barnes, Thomas R E ^b   Joyce, Eileen M ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

cognition; premorbid IQ; schizophrenia; trajectory; WAIS; WTAR

Indexed keywords

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MEMORY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; AWARENESS; COGNITION DISORDERS; COGNITIVE RESERVE; FEMALE; HUMANS; INTELLIGENCE; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; NEUROPSYCHOLOGICAL TESTS; PRACTICE (PSYCHOLOGY); PROGNOSIS; PSYCHOMETRICS; PSYCHOTIC DISORDERS; REFERENCE VALUES; REHABILITATION, VOCATIONAL; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; YOUNG ADULT;

EID: 79959722951     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbp143     Document Type: Article

References (70)

1. David AS, Malmberg S, Brandt L, Allebeck P, Lewis G. IQ and risk for schizophrenia: a population-based cohort study. Psychol Med. 1997;27:1311-1323. (Pubitemid 27494097)
2. Davidson M, Reichenberg A, Rabinowitz J, et al. Behavioral and intellectual markers for Schizophrenia in apparently healthy male adolescents. Am J Psychiatr. 1999;156:1328-1335. (Pubitemid 29416527)
3. Jones P, Murray R, Jones P, Rodgers B, Marmot M. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994;344:1398-1402. (Pubitemid 24365314)
4. Kremen WS, Buka SL, Seidman LJ, et al. IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study. Am J Psychiatr. 1998;155:672-677. (Pubitemid 28225409)
5. Cannon TD, Bearden CE, Hollister JM, et al. Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull. 2000;26:379-393. (Pubitemid 30423216)
6. Zammit S, Allebeck P, David AS, et al. A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatr. 2004;61:354-360. (Pubitemid 38451544)
7. Bilder RM, Reiter G, Bates JA, et al. Cognitive development in schizophrenia: follow back from first episode. J Clin Exp Neuropsychol. 2006;28:270-282. (Pubitemid 43254519)
8. Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatr. 2008;165:579-587. (Pubitemid 351705334)
9. Fuller R, Nopoulos P, Arndt S, et al. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatr. 2002;159:1183-1189. (Pubitemid 34743259)
10. Rabinowitz J, Reichenberg A, Weiser M, et al. Cognitive and behavioural functioning in men with schizophrenia both before and shortly after first admission to hospital. Cross-sectional analysis. Br J Psychiatr. 2000;177:26-32. (Pubitemid 30450660)
11. Gunnell D, Harrison G, Rasmussen F, Fouskakis D, Tynelius P. Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia: cohort study. Br J Psychiatr. 2002;181:298-305. (Pubitemid 35178561)
12. Cosway R, Byrne M, Clafferty R, et al. Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med. 2000;30:1111-1121.
13. Caspi A, Reichenberg A, Weiser M, et al. Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr Res. 2003;65:87-94. (Pubitemid 37434015)
14. Lencz T, Smith CW, McLaughlin D, et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatr. 2006;59:863-871.
15. Badcock JC, Dragovic M, Waters FAV, Jablensky A. Dimensions of intelligence in schizophrenia: evidence from patients with preserved, deteriorated and compromised intellect. J Psychiatr Res. 2005;39:11-19. (Pubitemid 39422281)
16. Joyce EM, Hutton SB, Mutsatsa SH, Barnes TRE. Cognitive heterogeneity in first-episode schizophrenia. Br J Psychiatr. 2005;187:516-522. (Pubitemid 41752740)
17. Kremen WS, Seidman LJ, Faraone SV, Tsuang MT. IQ decline in cross-sectional studies of schizophrenia: methodology and interpretation. Psychiatry Res. 2008;158:181-194.
18. Weickert TW, Goldberg TE, Gold JM, et al. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatr. 2000;57:907-913.
19. Sun D, Phillips L, Velakoulis D, et al. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res. 2009;108:85-92.
20. Cahn W, Rais M, Stigter FP, et al. Psychosis and brain volume changes during the first five years of schizophrenia. Eur Neuropsychopharmacol. 2009;19:147-151.
21. Szoke A, Trandafir A, Dupont ME, et al. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br J Psychiatr. 2008;192:248-257. (Pubitemid 351692396)
22. Gold S,Arndt S,NopoulosP,O'LearyDS,AndreasenNC.Longitudinal study of cognitive function in first-episode and recentonset schizophrenia. Am J Psychiatr. 1999;156:1342-1348.
23. Hoff AL, Svetina C, Shields G, Stewart J, DeLisi LE. Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr Res. 2005;78:27-34. (Pubitemid 41188322)
24. Frangou S, Hadjulis M, Vourdas A. The Maudsley early onset schizophrenia study: cognitive function over a 4-year follow-up period. Schizophr Bull. 2008;34:52-59. (Pubitemid 350262292)
25. The Scottish Schizophrenia Research Group. The Scottish first episode schizophrenia study V. One-year follow-up. Br J Psychiatr. 1988;152:470-476.
26. Townsend LA, Norman RMG, Malla AK, Rychlo AD, Ahmed RR. Changes in cognitive functioning following comprehensive treatment for first episode patients with schizophrenia spectrum disorders. Psychiatry Res. 2002;113:69-81. (Pubitemid 35447726)
27. Albus M, Hubmann W, Mohr F, et al. Neurocognitive functioning in patients with first-episode schizophrenia: results of a prospective 5-year follow-up study. Eur Arch Psychiatry Clin Neurosci. 2006;256:442-451. (Pubitemid 44584061)
28. Hill SK, Keshavan MS, Thase ME, Sweeney JA. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. Am J Psychiatr. 2004;161: 996-1003. (Pubitemid 38735985)
29. Goldberg TE, Goldman RS, Burdick KE, et al. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect? Arch Gen Psychiatr. 2007;64:1115-1122. (Pubitemid 47529336)
30. Addington J, Saeedi H, Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr Res. 2005;78:35-43. (Pubitemid 41188323)
31. Crespo-Facorro B, Rodriguez-Sanchez JM, Perez-Iglesias R, et al. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. J Clin Psychiatr. 2009;70:717-729.
32. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8:448-460. (Pubitemid 34296102)
33. Barnett JH, Salmond CH, Jones PB, Sahakian BJ. Cognitive reserve in neuropsychiatry. Psychol Med. 2006;36:1053-1064. (Pubitemid 44084009)
34. Leeson VC, Barnes TRE, Hutton SB, Ron MA, Joyce EM. IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis. Schizophr Res. 2009;107:55-60.
35. van Winkel R, Myin-Germeys I, De Hert M, et al. The association between cognition and functional outcome in first-episode patients with schizophrenia: mystery resolved? Acta Psychiatr Scand. 2007;116:119-124. (Pubitemid 47076272)
36. Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl. 1992;20:1-97.
37. Jablensky A,McGrath J, Herrman H, et al. Psychotic disorders in urban areas: an overviewof the Study onLow Prevalence Disorders. Aust N Z J Psychiatr. 2000;34:221-236. (Pubitemid 30206762)
38. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatr. 1991;48:764-770.
39. Wing JK, Babor T, Brugha T, et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatr. 1990;47:589-593. (Pubitemid 20189971)
40. Andreasen N. Methods for assessing positive and negative symptoms. Basel, Switzerland: Karger; 1990.
41. Liddle PF, Barnes TRE. Syndromes of chronic schizophrenia. Br J Psychiatr. 1990;157:558-561. (Pubitemid 20335968)
42. Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatr. 1990;157:853-859.
43. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr. 1960;23:56-62.
44. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatr. 1978;133:429-435. (Pubitemid 9006756)
45. Singh SP, Cooper JE, Fisher HL, et al. Determining the chronology and components of psychosis onset: the Nottingham Onset Schedule (NOS). Schizophr Res. 2005;80:117-130. (Pubitemid 41587470)
46. Foerster A, Lewis S, Owen M, Murray RM. Pre-morbid adjustment and personality in psychosis: effects of sex and diagnosis. Br J Psychiatr. 1991;158:171-176.
47. David AS. Insight and psychosis. Br J Psychiatr. 1990;156: 798-808. (Pubitemid 20207090)
48. Hayward P, Chan N, Kemp R, Youle S, David AS. Medication self management: a preliminary report on an intervention to improve medication compliance. J Ment Health. 1995;4:511-517. (Pubitemid 26009202)
49. Wechsler D. Wechsler Adult Intelligence Scale-3rd Edition (WAIS-3). San Antonio, TX: Harcourt Assessment; 1997.
50. Blyler CR, Gold JM, Iannone VN, Buchanan RW. Short form of the WAIS-III for use with patients with schizophrenia. Schizophr Res. 2000;46:209-215.
51. Wechsler D. The Wechsler Test of Adult Reading (WTAR). San Antonio, TX: The Psychological Corporation; 2001.
52. Lezak MD. Neuropsychological assessment. New York: Oxford University Press; 2004.
53. OwenAM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW. Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia. 1990;28:1021-1034. (Pubitemid 20347464)
54. van Winkel R, Myin-Germeys I, Delespaul P, et al. Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: a 10-year follow-up study. Schizophr Res. 2006;88:47-54. (Pubitemid 44693234)
55. Cahn W, van Haren NEM, Pol HEH, et al. Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br J Psychiatr. 2006;189:381-382. (Pubitemid 44606754)
56. Yung AR, Killackey E, Hetrick SE, et al. The prevention of schizophrenia. Int Rev Psychiatr. 2007;19:633-646. (Pubitemid 351185556)
57. Lieberman JA, Buckley PF, Perkins DO. Neuroprotection: a new strategy in the treatment of schizophrenia. CNS Spectrums. 2007;12(10 suppl 18):1-16.
58. Cohen JD, Insel TR. Cognitive neuroscience and schizophrenia: translational research in need of a translator. Biol Psychiatr. 2008;64:2-3. (Pubitemid 351783248)
59. Leeson VC, Robbins TW, Franklin C, et al. Dissociation of long term verbal memory and fronto-executive impairment in first-episode psychosis. Psychol Med. 2009;39:1799-1808.
60. Crawford JR, Parker DM, Stewart L. Prediction of WAIS IQ with the National Adult Reading Test; cross validation and extension. Br J Clin Psychol. 1989;28:267-273. (Pubitemid 19229160)
61. Crawford JR, Deary IJ, Starr J, Whalley JL. The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval. Psychol Med. 2001;31:451-458. (Pubitemid 32294043)
62. Nelson HE, O'Connell A. Dementia: the estimation of premorbid intelligence levels using the new adult reading test. Cortex. 1978;14:234-244. (Pubitemid 8386900)
63. O'Carroll R. The assessment of pre-morbid ability. A critical review. Neurocase. 1995;1:83-89.
64. O'Carroll R, Walker M, Duncan J. Selecting controls for schizophrenia research studies: the use of the National Adult Reading Test (NART) as a measure of pre-morbid ability. Schizophr Res. 1992;8:137-141.
65. Crawford JR, Besson JA, Bremner M, et al. Estimation of premorbid intelligence in schizophrenia. Br J Psychiatr. 1992;161:69-74.
66. Morrison G, Sharkey V, Allardyce J. Nithsdale schizophrenia surveys: a longitudinal study of National Adult Reading Test stability. Psychol Med. 2000;30:717-720. (Pubitemid 30410333)
67. Smith D, Roberts S, Brewer W, Pantelis C. Test-retest reliability of the National Adult Reading Test (NART) as an estimate of premorbid IQ in patients with schizophrenia. Cognit Neuropsychiatry. 1998;3:71-80. (Pubitemid 128534196)
68. Barber F, Pantelis C, Bodger S, Nelson HE. Intellectual functioning in schizophrenia: natural History. Chichester, UK: John Wiley; 1996.
69. Eberhard J, Riley F, Levander S. Premorbid IQ and schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2003;253: 84-88.
70. Russell AJ, Munro J, Jones P, et al. The National Adult Reading Test as a measure of premorbid IQ in schizophrenia. Br J Clin Psychol. 2000;39:297-305.